Photodynamic therapy repairs medication-related osteonecrosis of the jaw by reducing NF-kB protein in rats
DOI:
https://doi.org/10.1590/1678-7757-2023-0447Keywords:
Osteonecrosis, Bisphosphonates, Dentistry, Antimicrobial Photodynamic Therapy, NF-kappa BAbstract
To evaluate whether antimicrobial photodynamic therapy (aPDT) repairs bisphosphonate-related osteonecrosis of the jaw (BRONJ) modulated by the reduction of NF-kB protein in a murine model. Methodology: Male Wistar rats (N=30) were divided into the following groups (n=6/group): negative control (NC); experimental osteonecrosis (ONE); ONE + photosensitizer (PS); ONE + photobiomodulation (PBM); and ONE + aPDT. Over 8 weeks, ONE was induced by zoledronic acid 250 µg/kg injections, except in the NC group, which received sterile 0.9% saline, followed by extraction of the lower left first molar. Red light laser irradiation (wavelength ~660 nm, power 50 mW, energy of 2 J, energy dose of 66.67 J/cm2 for 40 s) was performed once a week for 4 weeks. Methylene blue 0.3% was used as PS. The animals were euthanized and examined macroscopically for the presence of exposed bone and epithelial repair and microscopically by histochemical (hematoxylin-eosin and Masson’s trichrome staining) and immunohistochemical (anti-NF-kB) methods. Macroscopic and histomorphometric data were analyzed by one-way ANOVA and Tukey’s post-test (p<0.05). Results: Mucosal repair, viable osteocytes, and NF-kB immunostaining were observed in the NC, ONE+PS, ONE+PBM, and ONE+aPDT groups. The ONE group showed no mucosal repair, showing empty lacunae and multifocal immunostaining for NF-kB. The ONE+PBM and ONE+aPDT groups had greater deposition of extracellular matrix and less necrotic bone tissue (p<0.05). Conclusion: PBM and aPDT treatments for BRONJ were effective for bone and epithelial repair, in addition to reducing inflammation mediated by the decrease of NF-kB protein in the irradiated regions.
Downloads
References
Fusco V, Mauceri R, Campisi G, Bedogni A. RE: American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update: quantitative risk assessment and controversial issues. J Oral Maxillofac Surg. 2022;80(12):1871-3. doi: 10.1016/j.joms.2022.07.143
Corral-Gudino L, Tan AJ, Ralston SH. Bisphosphonates for Paget’s disease of bone in adults. Cochrane Database Syst Rev. 2017;12(12):CD004956. doi: 10.1002/14651858.CD004956.pub3
O’Carrigan B, Wong MH, Willson ML, Stockler MR, Pavlakis N, Goodwin A. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2017;10(10):CD003474. doi:10.1002/14651858.CD003474.pub4
Poli PP, Souza FA, Ferrario S, Maiorana C. Adjunctive application of antimicrobial photodynamic therapy in the prevention of medication-related osteonecrosis of the jaw following dentoalveolar surgery: a case series. Photodiagnosis Photodyn Ther. 2019;27:117-23. doi: 10.1016/j.pdpdt.2019.05.037
Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone. 2008;42(5):848-60. doi: 10.1016/j.bone.2007.12.225
Hamadeh IS, Ngwa BA, Gong Y. Drug induced osteonecrosis ofthe jaw. Cancer Treat Rev. 2015;41(5):455-64. doi: 10.1016/j.ctrv.2015.04.007
Lombard T, Neirinckx V, Rogister B, Gilon Y, Wislet S. Medication-related osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches. Stem Cells Int. 2016;2016:8768162. doi: 10.1155/2016/8768162
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23. doi: 10.1002/jbmr.2405
Limones A, Sáez-Alcaide LM, Díaz-Parreño SA, Helm A, Bornstein MM, Molinero-Mourelle P. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cirugia Bucal. 2020;25(3):e326-36. doi: 10.4317/medoral.23324
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115-7. doi: 10.1016/S0278-2391(03)00720-1
Anesi A, Generali L, Sandoni L, Pozzi S, Grande A. From osteoclast differentiation to osteonecrosis of the jaw: molecular and clinical insights. Int J Mol Sci. 2019;20(19):4925. doi: 10.3390/ijms20194925
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws—2022 update. J Oral Maxillofac Surg. 2022;80(5):920-43. doi: 10.1016/j.joms.2022.02.008
Wainwright M, Maisch T, Nonell S, Plaetzer K, Almeida A, Tegos GP, et al. Photoantimicrobials-are we afraid of the light? Lancet Infect Dis. 2017;17(2):e49-e55. doi: 10.1016/S1473-3099(16)30268-7
Ervolino E, Statkievicz C, Toro LF, Mello-Neto JM, Cavazana TP, Issa JPM, et al. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone.2019;120:101-13. doi: 10.1016/j.bone.2018.10.014
Carrera ET, Dias HB, Corbi SC, Marcantonio RA, Bernardi AC, Bagnato VS, et al. The application of antimicrobial photodynamic therapy (aPDT) in dentistry: a critical review. Laser Phys. 2016;26(12):123001. doi: 10.1088/1054-660X/26/12/123001
Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):7000417. doi:10.1109/JSTQE.2016.2561201
Statkievicz C, Toro LF, Mello-Neto JM, Sá DP, Casatti CA, Issa JPM, et al. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats. J Photochem Photobiol B. 2018;184:7-17. doi: 10.1016/j.jphotobiol.2018.05.004
Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, et al. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. 2014;50(11):1049-57. doi: 10.1016/j.oraloncology.2014.08.016
Biguetti CC, Oliva AH, Healy K, Mahmoud RH, Custódio IDC, Constantino DH, et al. Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization. PLoS One. 2019;14(6):e0214173. doi: 10.1371/journal.pone.0214173
Flecknell PA. Laboratory animal anaesthesia. 3rd ed. Elsevier/Academic Press; 2009.
Brasil. Ministério da Ciência, Tecnologia e Inovação. Conselho Nacional de Controle de Experimentação Animal. Diretriz da prática de eutanásia do CONCEA [Internet]. Brasília, DF: CONCEA; 2018 [cited 2023 Aug 22]. Portuguese. Available from: https://antigo.mctic.gov.br/mctic/export/sites/institucional/legislacao/Arquivos/Anexo_Res_Norm_37_2018_CONCEA_Pratica_Eutanasia.pdf
Lima WJ, Pontes JC, Figueiredo LS, Araújo RD, Sousa MC, Aquino JS, et al. Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats. J Appl Oral Sci. 2023;31:e20230133. doi: 10.1590/1678-7757-2023-0133
Silva PG, Oliveira CC, Brizeno L, Wong D, Lima R Júnior, Gonçalves RP,et al. Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw. Oral Dis. 2016;22(7):649-57. doi: 10.1111/odi.12513
Williams DW, Lee C, Kim T, Yagita H, Wu H, Park S, et al. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice. Am J Pathol. 2014;184(11):3084-93. doi: 10.1016/j.ajpath.2014.07.010
Huang XL, Huang LY, Cheng YT, Li F, Zhou Q, Wu C, et al. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways. Int J Mol Med. 2019;44(2):582-92. doi: 10.3892/ijmm.2019.4207
He J, Zhou Q, Jia X, Zhou P, Chen L. Immune-related expression profiles of bisphosphonates-related osteonecrosis of the jaw in multiple myeloma. Pharmazie. 2021;76(4):159-64. doi: 10.1691/ph.2021.01013
Marx RE. Bone and bone graft healing. Oral Maxillofac Surg Clin N Am. 2007;19(4):455-66. doi: 10.1016/j.coms.2007.07.008
Silva PG, Ferreira AE Junior , Oliveira CC, Brizeno LA, Wong DV, Lima RC Júnior, et al. Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats. J Oral Pathol Med. 2017;46(10):1046-53. doi: 10.1111/jop.12640
Kuiper J, Forster C, Sun C, Peel S, Glogauer M. Zoledronate and pamidronate depress neutrophil functions and survival in mice. Br J Pharmacol. 2012;165(2):532-39. doi: 10.1111/j.1476-5381.2011.01592.x
Carroll JD, Milward MR, Cooper PR, Hadis M, Palin WM. Developments in low level light therapy (LLLT) for dentistry. Dent Mater. 2014;30(5):465-75. doi: 10.1016/j.dental.2014.02.006
Alsalih A, Dam A, Lindberg P, Truedsson A. Medication-related osteonecrosis of the jaws initiated by zoledronic acid and potential pathophysiology. Dent J (Basel). 2021;9(8):85. doi: 10.3390/dj9080085
Kozutsumi R, Kuroshima S, Kaneko H, Sasaki M, Ishisaki A, Sawase T. Zoledronic acid deteriorates soft and hard tissue healing of murine tooth extraction sockets in a dose-dependent manner. Calcif Tissue Int. 2022;110(1):104-16. doi: 10.1007/s00223-021-00890-9
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23
Nica DF, Heredea ER, Todea DC. Alveolus soft and bone tissue regeneration after laser biomodulation: a histological study. Rom J Morphol Embryol. 2019;60(4):1269-73.
Vescovi P, Giovannacci I, Merigo E, Meleti M, Manfredi M, Fornaini C, et al. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy. J Craniofac Surg. 2015;26(3):696-9. doi: 10.1097/SCS.0000000000001665
Tartaroti NC, Marques MM, Naclério-Homem MD, Migliorati CA, Deboni MC. Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: case series and long-term follow-up. Photodiagnosis Photodyn Ther. 2020;29:101651. doi: 10.1016/j.pdpdt.2020.101651
Almeida MV, Moura AC, Santos L, Gominho L, Cavalcanti UD, Romeiro K. Photodynamic therapy as an adjunct in the treatment of medication-related osteonecrosis of the jaw: a case report. J Lasers Med Sci. 2021;12:e12. doi: 10.34172/jlms.2021.12
Scribante A, Gallo S, Pascadopoli M, Frani M, Butera A. Ozonized gels vs chlorhexidine in non-surgical periodontal treatment: a randomized clinical trial. Oral Dis. Forthcoming 2023. doi:10.1111/odi.14829
Butera A, Maiorani C, Gallo S, Pascadopoli M, Venugopal A, Marya A, et al. Evaluation of adjuvant systems in non-surgical peri-implant treatment: a literature review. Healthcare (Basel). 2022;10(5):886. doi: 10.3390/healthcare10050886
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Applied Oral Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.
